•  
  •  
  •  
  •  

2026-08-05 11:21:26

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore

Keywords Selected:  Pharmaceuticals

Research

  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • GPCB Revokes Closure Notice for Aarti Drugs' Sayakha Plant; Operations Resume Following EDC Payment
  • Zydus Lifesciences Ltd receives EIR from the USFDA for its injectable facility with VAI classification
  • Divi's Laboratories Reports Strong Q1 FY27 Results: Consolidated PAT Soars 65% YoY to ₹902 Crore
  • Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-Term Strategic Growth
  • Glenmark Pharmaceuticals Announces Q1 FY27 Results
  • Lupin Announces the Approval of Diazepam Injection, USP in the United States
  • Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
  • Concord Biotech Limited Reports Q1 FY27 Results: Revenue Rises 26.2% YoY to ₹25,748.90 Lakhs
  • CORONA Remedies Reports Strong Q1 FY27 Performance: PAT Up 30.1% YoY to ₹60.1 Crore
  • SMS Pharmaceuticals Limited Reports Unaudited Financial Results for Q1 FY27
  • Strides Pharma Science Limited Reports Strong Net Profit Growth for Q1 FY27
  • Torrent Pharmaceuticals Limited Reports Q1 FY27 Results: Revenue Surges 55% YoY to ₹4,921 Crore; Net Profit Reaches ₹566 Crore
  • Mankind Pharma Reports Strong Q1 FY27 Results with Consolidated Net Profit Rising 29% to ₹574.09 Crore
  • Hester Biosciences Reports Q1 FY27 Results: Exceptional Gain Drives Consolidated Net Profit Up 459% to ₹967.32 Million
  • No DMF deficiency letter received from the office of USFDA for multiple ANDAs
  • Glenmark Pharmaceuticals Inc., USA launches Sugammadex Injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) Single-Dose Vials
  • RPG Life Sciences Reports Q1 FY27 Results: Consolidated Net Profit Up 17% YoY to ₹30.76 Crore
  • Sanofi Consumer Healthcare India Limited reports Q2'26 Revenue at ₹2,357 MN, Net Profit at ₹919 MN
  • Pfizer Limited Reports ₹204.47 Crore Net Profit for Q1 FY27; Operating Revenue Rises 8.3% YoY
  • Alembic Pharmaceuticals Limited receives USFDA Final Approval for Prucalopride Tablets, 1 mg and 2 mg
  • Indoco Remedies Reports Turnaround in Q1 FY27 with Net Profit of ₹65.44 Crore Driven by Exceptional Gain
  • Aurobindo Pharma signs non-exclusive voluntary license agreement with MSD
  • Laurus Labs Reports Exceptional Q1 FY27 Results: Consolidated Net Profit Surges 126% YoY to ₹362 Crore; EBITDA Margins Expand to 31.8%

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Deepening Our Presence in Punjab - Strengthening the Tricity Cluster
  • Mini Diamonds India Reports Strong Q1 FY27 Performance: Consolidated Net Profit Up 49.8% YoY to ₹2.67 Crore; Revenue Nearly Doubles to ₹196.53 Crore
  • Kinetic Engineering Reports Q1 FY27 Results: Net Loss at ₹12.96 Crore Amid Higher Material Costs and Inventory Movements
  • Blue Jet Healthcare Reports Q1 FY27 Results: Net Profit Reaches ₹78.26 Crore; Revenue Up 24.9% QoQ
  • One Mobikwik Systems Turns Profitable in Q1 FY27: Reports Net Profit of ₹7.62 Crore; EBITDA Reaches ₹15.78 Crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025